Caliway Files US IND for Phase 2 Study Combining C...
Category : Clinical Trial Update 26 December 2025Caliway Biopharmaceuticals has taken a decisive step into the next phase of weight management innova...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Mabwell Secures US FDA IND Clearance for Anti-ST2...
Category : Clinical Trial Update 26 December 2025Mabwell has received IND clearance from the US FDA to advance its anti-ST2 monoclonal antibody, 9MW1...
Sanofi and Regeneron receives Japanese marketing a...
Category : Approval/Launch 24 December 2025The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authoriz...
AusperBio completes patient enrollment in phase II...
Category : Clinical Trial Update 24 December 2025AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage b...
Ipsen’s Phase II FALKON Trial Fails to Meet Primar...
Category : Clinical Trial Update 23 December 2025Ipsen has announced a setback in its rare disease pipeline. The company will discontinue the pivotal...
Latest Newsletter Post
-
Mabwell Secures US FDA IND Clearanc..
26 December 2025
-
Caliway Files US IND for Phase 2 St..
26 December 2025
-
AusperBio completes patient enrollm..
24 December 2025
-
Sanofi and Regeneron receives Japan..
24 December 2025
-
GC Biopharma Secures South Korea IN..
23 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com